SCHEMBL18800651

SCHEMBL18800651

Cc1cc(C)cc(-c2ncc(-c3ccc(Oc4ccccc4)cc3)c(C(=N)N)c2N)c1

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 14/20 0.43
▸ TNK2 Q07912 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800753 0.90 BTK (0.49) BTKTNK2
SCHEMBL18800564 0.89 BTK (0.47) BTKTNK2
SCHEMBL18800492 0.88 BTK (0.48) BTKTNK2
SCHEMBL18800616 0.87 BTK (0.47) BTKTNK2
SCHEMBL18800747 0.86 KMT2A (0.46) BTKTNK2
SCHEMBL18800770 0.85 BTK (0.57) BTKTNK2
SCHEMBL18800661 0.85 ADORA1 (0.47) BTKTNK2
SCHEMBL18800769 0.85 ADORA2A (0.48) BTKTNK2
SCHEMBL18800775 0.83 TNK2 (0.48) BTKTNK2
SCHEMBL18800757 0.82 TNK2 (0.49) BTKTNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback